Difference between revisions of "R-roscovitine"

From Xenbase
Jump to: navigation, search
(Created page with "==Description== "R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines,...")
 
(Description)
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
 
"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."  
 
"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."  
  
Source:  
+
Source: Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733
 
 
Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733
 
 
 
 
 
[[File:Olomoucine.png|frame|right|Olomoucine structure, photo from Sigma-Aldrich]]
 

Latest revision as of 12:27, 12 September 2019

Description

"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."

Source: Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733